Zobrazeno 1 - 10
of 47
pro vyhledávání: '"V Sainio"'
Autor:
Reijo Haapiainen, Pauli Puolakkainen, Jorma Halttunen, V Sainio, U H Stenman, Esko Kemppainen, Eero Kivilaakso, J Hedström
Publikováno v:
Gut. 41:690-695
Aims—To evaluate the clinical utility of two new tests for serum trypsinogen 2 and trypsin 2-α1antitrypsin complex (trypsin 2-AAT) in diagnosing and assessing the severity of acute pancreatitis (AP) induced by endoscopic retrograde cholangiopancre
Autor:
J Hedström, U H Stenman, Pauli Puolakkainen, Esko Kemppainen, V Sainio, Jorma Halttunen, Reijo Haapiainen
Publikováno v:
Endoscopy. 29:247-251
BACKGROUND AND STUDY AIMS We have evaluated a new urinary trypsinogen-2 test strip, based on the principle of immunochromatography, in the diagnosis of acute pancreatitis induced by endoscopic retrograde cholangiopancreatography (ERCP). PATIENTS AND
Autor:
S. Laine, Reijo Haapiainen, J Sand, J Hedström, Pauli Puolakkainen, V Sainio, Esko Kemppainen, I Nordback
Publikováno v:
Gut. 39:675-678
BACKGROUND: Measuring serum pancreatitis associated protein (PAP) in acute pancreatitis has proved valuable to monitoring the course of the disease and the recovery of the patient. AIMS: The aim was to analyze the utility of PAP on admission as a dia
Autor:
V Sainio, Eero Kivilaakso, Ulf-Håkan Stenman, Jari Leinonen, Reijo Haapiainen, Tom Schröder, Esko Kemppainen, J Hedström
Publikováno v:
BMJ. 313:333-337
Objective: To estimate the usefulness of serum concentrations of the complex of trypsin 2 and (alpha)1 antitrypsin in diagnosing and assessing the severity of acute pancreatitis in comparison with serum C reactive protein, amylase, and trypsinogen 2
Autor:
Pauli Puolakkainen, Eero Kivilaakso, Johan Hedström, Ulf-Håkan Stenman, V Sainio, Esko Kemppainen, Reijo Haapiainen, K O Schauman
Publikováno v:
Clinical Chemistry. 42:685-690
We examined the clinical utility of urine trypsinogen-2 as a marker of acute pancreatitis (AP). Fifty-nine patients with AP, 42 with acute abdominal diseases of extrapancreatic origin, and 63 without evidence of acute abdominal disease were studied.
Publikováno v:
Clinical Chemistry. 40:1761-1765
We developed a sensitive time-resolved immunofluorometric assay (IFMA) for trypsin-2 complexed with alpha 1-antitrypsin (AAT). We used a trypsin-2-specific monoclonal antibody on the solid phase and a europium-labeled polyclonal antibody to AAT as tr
Publikováno v:
Annales chirurgiae et gynaecologiae. 87(3)
The treatment of mild acute pancreatitis (AP) with fluid replacement and other conservative measures is adequate and sufficient in the majority of patients. The corner-stones of the treatment of patients with severe acute pancreatitis include early a
Autor:
Pauli Puolakkainen, V Sainio, Leena Kivisaari, J Hedström, Eero Kivilaakso, U H Stenman, Esko Kemppainen, Reijo Haapiainen, Tom Schröder
Publikováno v:
Scandinavian journal of gastroenterology. 31(8)
Background: The accuracy of serum trypsinogen-2 in predicting the severity of acute necrotizing pancreatitis (ANP) was prospectively evaluated in 52 consecutive patients. Methods: A new sensitive immunofluorometric assay was used for serum trypsinoge
Autor:
Reijo Haapiainen, Eero Kivilaakso, Esko Kemppainen, Pauli Puolakkainen, V Sainio, Leena Kivisaari
Publikováno v:
The British journal of surgery. 83(7)
A total of 161 primary contrast-enhanced computed tomography (CT) scans of patients with acute necrotizing pancreatitis taken between 1982 and 1994 were analysed retrospectively. The aim was to assess the prognostic significance of the extent and ana
Autor:
Tom Schröder, M Taavitsainen, Ville Valtonen, Esko Kemppainen, Reijo Haapiainen, Eero Kivilaakso, L Kivisaarl, Pauli Puolakkainen, V Sainio
Publikováno v:
Lancet (London, England). 346(8976)
Despite improvements in surgical treatment and intensive care, mortality from severe acute pancreatitis remains high. We have carried out a randomised study of 60 consecutive patients with alcohol-induced necrotising pancreatitis to find out whether